Cart
sales@molnova.com
Deoxyspergualin
CAS No. 98629-43-7
Deoxyspergualin( 15-deoxyspergualin | Spanidin | NSC 356894 | NKT-01 )
Catalog No. M16896 CAS No. 98629-43-7
Deoxyspergualin is a derivative of the antitumor antibiotic spergualin that binds specifically to Hsc70.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1593 | Get Quote |
|
| 50MG | 3222 | Get Quote |
|
| 100MG | 4410 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDeoxyspergualin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDeoxyspergualin is a derivative of the antitumor antibiotic spergualin that binds specifically to Hsc70.
-
DescriptionDeoxyspergualin is a derivative of the antitumor antibiotic spergualin that binds specifically to Hsc70, also inhibits poly(rC) binding protein 2 (PCBP2).
-
In Vitro——
-
In Vivo——
-
Synonyms15-deoxyspergualin | Spanidin | NSC 356894 | NKT-01
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98629-43-7
-
Formula Weight387.53
-
Molecular FormulaC17H37N7O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC(O)C(NCCCCNCCCN)=O)CCCCCCNC(N)=N
-
Chemical Name7-[(Aminoiminomethyl)amino]-N-[2-[[4-[(3-aminopropyl)amino]butyl]amino]-1-hydroxy-2-oxoethyl]heptanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nadler SG, et al. Science. 1992 Oct 16;258(5081):484-6.
2. Panjwani N, et al. J Immunol. 1999 Aug 15;163(4):1936-42.
3. Murahashi M, et al. Biochem Biophys Res Commun. 2016 Aug 5;476(4):445-9.
molnova catalog
related products
-
PU-WS13
A potent and selective Grp94 inhibitor with Ic50 of 0.22 uM.
-
Ochromycinone
STA-21 is a selective STAT3 inhibitor.
-
ITZ-1
ITZ-1 is a client-selective Hsp90 inhibitor that efficiently induces heat shock factor 1 (HSF1) activation, selectively inhibits IL-1β-induced MMP-13 production (IC50=0.51 uM) via inhibition of ERK activation.
